Urology for Practice, 2007, issue 3

Editorial

Slovo úvodem

MUDr. Ivan Kolombo FEBU

Urolog. pro Praxi, 2007; 3: 103  

Review articles

Traumatic lower urinary tract dysfunction: aetiology, prevalence and classification

doc. MUDr. Roman Zachoval Ph.D, MUDr. Jan Krhut

Urolog. pro Praxi, 2007; 3: 109-112  

Spinal cord injury is caused by a trauma in 70 % of patients, usually as a result of a trauma to the spinal cord. Incidence of spinal cord injury is estimated at 14 /1 000 000 worldwide and the number of new cases in Czech republic vary from 200 to 300 per a year. Neurogenic dysfunctions of lower urinary tract develop in 80 % of these patients. The principal point of the classification of lower urinary tract dysfunctions is the description of the affection of the both functional units: detrusor and urethral sphincters.

Prostatic syndrome - bacterial inflamation

MUDr. Kamil Belej FEBU

Urolog. pro Praxi, 2007; 3: 113-118  

A causative pathogen in patient with prostatitis is detected by routine methods in less than 10 % of cases. This is classified as bacterial prostatitis and for these patients an antimicrobial therapy is performed on a rational basis. According to the duration of symptoms bacterial prostatitis can be described as either acute or chronic. Important investigations in the evaluation of the patient with chronic prostatitis are quantitative bacteriological cultures and microscopy of the urine, expressed prostatic secretion or semen. Antiobiotics and other drugs are used according to clinical status of patient, course of the disease and result of microscopic...

Benign prostate hypertrophy and contemporary trend in the treatment

MUDr. Jiří Klečka Ph.D, doc. MUDr. Milan Hora Ph.D

Urolog. pro Praxi, 2007; 3: 120-126  

This article summarize contemporary oppurtunities of miniinvasive treatment of the patientes with benign prostate hypertrophy (BPH). Uptodate pharmacological traetment offers to the patients good quality of life and decreased the risk of surgical intervention. Transurethral resection of the prostate (TUR-P) is still the golden standard of the treatment of BPH. The total number of the patientes treated by TUR-P is at present slowly decreasing. The reason is boom in miniinvasive methods, witch enable reaching the same or better resultes like the TURP with advantage of minimization of bleeding and TUR- syndrome. The other advantage is very short time...

Hormonal milieu of prostate cancer and new options for its management

Michaela Matoušková

Urolog. pro Praxi, 2007; 3: 128-131  

The incidence of malignant prostate tumours has been steadily increasing in recent decades making prostate cancer one of the most common male malignancies. In European countries, it accounts for approximately 16 % of malignant tumours in men. In European Union countries, 237,800 cases were diagnosed in 2004; the incidence in the Czech Republic was 83.4/100,000 (18). The mortality rate is about 4 % and does not vary much. Curative treatment is possible only in localized forms of the disease. The biological nature of the disease allows for long-term stabilization even in more advanced stages of the condition. The management of advanced forms...

Case report

Embryonální rabdomyosarkom ledvinové pánvičky

MUDr. Matúš Chocholatý, doc. MUDr. Ivan Kawaciuk CSc, MUDr. Josef Mališ, MUDr. Pavel Dušek, doc. MUDr. Josef Zámečník Ph.D

Urolog. pro Praxi, 2007; 3: 133-134  

Difuzní fibrotická proliferace nadvarlete

MUDr. František Kučera

Urolog. pro Praxi, 2007; 3: 135-136  

For nurses

Laparoskopická radikální prostatektomie

Miroslava Lahodová

Urolog. pro Praxi, 2007; 3: 137  

Inkontinence, problém nejen zdravotní, ale i společenský

Bohumila Jančová

Urolog. pro Praxi, 2007; 3: 138  

Information

Androgenní suplementace při hypogonadizmu

Miroslav Hanuš

Urolog. pro Praxi, 2007; 3: 140  

Urologická konference - mezioborová spolupráce, Olomouc, 31. 5. 07

MUDr. Karel Grepl, Mgr. Eva Kultanová

Urolog. pro Praxi, 2007; 3: 142  


Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.